As of December 31, 2019, euromicron AG has 10.05M shares outstanding.
| Shares Outstanding | 10.05M |
These figures are as of December 31, 2019.
| P/TBV Ratio | -0.01 |
| P/FCF Ratio | -0.15 |
| P/OCF Ratio | -0.13 |
These figures are as of December 31, 2019. euromicron AG trades at an EV/FCF ratio of 17.58, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.
| EV / FCF | 17.58 |
As of December 31, 2019, euromicron AG maintains a current ratio of 0.65, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -122.97, indicating conservative leverage, while an interest coverage ratio of -2.37 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.65 |
| Quick Ratio | 0.01 |
| Debt / Equity | -122.97 |
| Debt / EBITDA | -8.18 |
| Interest Coverage | -2.37 |
These figures cover the twelve months ended December 31, 2019. Return on assets (ROA) is negative at -78.95, reflecting losses generated across the asset base. Inventory turnover of 0.37 indicates how many times euromicron AG sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -78.95 |
| Inventory Turnover | 0.37 |
These figures cover the twelve months ended December 31, 2019. Free cash flow yield is negative at -657.95: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -3,875.55, meaning euromicron AG raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -3,875.55 |
| FCF Yield | -657.95 |
As of December 31, 2019, euromicron AG has an Altman Z-Score of -2.72, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.72 |
Already premium?